DFS
GILD icon

Dixon Fnancial Services’s Gilead Sciences GILD Stock Holding History

Dixon Fnancial Services’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,960
Closed -$297K – 28
2023
Q3 		$297K Hold
3,960
– – 0.2% 18
2023
Q2 		$305K Buy
+3,960
New +$316K 0.2% 19

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dixon Fnancial Services's GILD Position: Q4 2023 in Review

Dixon Fnancial Services sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 3,960 shares — an estimated $297K sold.

Dixon Fnancial Services first reported a position in GILD in Q2 2023 and held it in 2 quarters. The position peaked at $305K in Q2 2023. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • Dixon Fnancial Services reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
  • Dixon Fnancial Services sold 3,960 Gilead Sciences shares in Q4 2023, an estimated $297K.
  • Dixon Fnancial Services first reported a position in Gilead Sciences in Q2 2023 and held it in 2 quarters.
  • Dixon Fnancial Services's Gilead Sciences position peaked at $305K in Q2 2023.
  • 1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Dixon Fnancial Services's 13F filing for Q4 2023, filed 12 Jan 2024.